Abstract
Colchicine, a medication commonly used for the treatment of gout and other inflammatory conditions, is known to cause various adverse effects, including myopathy. We present a case of colchicine-induced myopathy in a 58-year-old male with a history of gout. The patient developed progressive muscle weakness after initiating colchicine therapy. Prompt discontinuation of colchicine resulted in resolution of symptoms and normalization of muscle enzyme levels. This case underscores the importance of recognizing colchicine-induced myopathy and prompt discontinuation of the medication to prevent further complications and report also highlights the challenges and considerations in managing a patient with multiple comorbidities and the importance of close follow-up and ongoing monitoring. Keywords: Colchicine, Myopathy, Gout, Adverse effects, Muscle weakness
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
